ããã³ ããªã¯ 100åèé ¸ã«å¼·ã*2 BE80èé åã ããã£ãºã¹èBE80ã¯ã å½ç¤¾å¾æ¥åã«å¯¾ã㦠ç´100åé«ãèé ¸èæ§ã§ãã èé ¸ã«è² ãããçãã¦è ¸ã¾ã§å±ãã¦ã åçèãããå¢ãã*3 ãã¨ãã§ãã¾ãã *2 å½ç¤¾å¾æ¥åæ¯ã第ä¸è æ©é¢ã«ããã¦èã®ç°å¢ã模ãã å®é¨å¨å ·ãç¨ãã¦ãBE80èã¨å½ç¤¾ã®ãã«ã¬ãªã«ã¹èã¨ã® è液殺èåã«å¯¾ããçåæ¯è¼è©¦é¨ã®çµæã *3 2é±éæå試é¨ã§è ¸å ã®ããã£ãºã¹èã®å²åãã å½ç¤¾å¾æ¥åæ¯ã§1.8å ï¼Pharmacometrics 74(5/6)99-106(2008)ï¼
{{#tags}}- {{label}}
{{/tags}}